← Back to Search

Behavioral Intervention

CLIPP2 for Prostate Cancer (CLIPP2 Trial)

N/A
Waitlist Available
Led By Amit Algotar, MD, PhD, MPH
Research Sponsored by University of Arizona
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights

CLIPP2 Trial Summary

This trial will study whether it's possible to get prostate cancer survivors who have been on hormone therapy to stick to a lifestyle modification program.

Eligible Conditions
  • Prostate Cancer

CLIPP2 Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Adherence to Intervention
Reach Recruiting Target
Retention of Participants
Secondary outcome measures
CBC
CMP
Fasting Glucose
+4 more
Other outcome measures
Angiogenic Pathways Associated with Prostate Cancer
Inflammatory Pathways Associated with Prostate Cancer

CLIPP2 Trial Design

1Treatment groups
Experimental Treatment
Group I: CLIPP2Experimental Treatment1 Intervention
24 Week Lifestyle Modification Intervention

Find a Location

Who is running the clinical trial?

University of ArizonaLead Sponsor
514 Previous Clinical Trials
148,558 Total Patients Enrolled
9 Trials studying Prostate Cancer
1,298 Patients Enrolled for Prostate Cancer
M.D. Anderson Cancer CenterOTHER
2,973 Previous Clinical Trials
1,789,285 Total Patients Enrolled
95 Trials studying Prostate Cancer
29,704 Patients Enrolled for Prostate Cancer
Amit Algotar, MD, PhD, MPHPrincipal InvestigatorUniversity of Arizona
1 Previous Clinical Trials
9 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Contemporary Clinical Trials CommunicationsJournal
Protocol for a Feasibility and Early Efficacy Study of the Comprehensive Lifestyle Improvement Program for Prostate Cancer-2 (CLIPP2)
Algotar, A.M., R. Kumar, H.M. Babiker, S.T. Dougherty, C.H. Hsu, H.-H. Chow, T.E. Smith, et al.. 2021. “Protocol for a Feasibility and Early Efficacy Study of the Comprehensive Lifestyle Improvement Program for Prostate Cancer-2 (CLIPP2)”. Contemporary Clinical Trials Communications. Elsevier BV. doi:10.1016/j.conctc.2021.100701.
clinicaltrials.govStudy
Comprehensive Lifestyle Improvement Program for Men With Prostate Cancer2 (CLIPP2)
2020. "Comprehensive Lifestyle Improvement Program for Men With Prostate Cancer2 (CLIPP2)". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04228055.
~8 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top